| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/06/2013 | CN202714946U Estrus synchronization vagina embolism for sheep |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918086A Supercritical fluid treatment of high molecular weight biopolymers |
| 02/06/2013 | CN102917722A Aqueous formulations for coating microneedle arrays |
| 02/06/2013 | CN102917696A Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day |
| 02/06/2013 | CN102917690A Lipid vesicle compositions and methods of use |
| 02/06/2013 | CN102917688A Novel process |
| 02/06/2013 | CN102917686A Novel self-reversible reverse latex, and use thereof as a thickening agent in a cosmetic composition |
| 02/06/2013 | CN102911368A Amphiphilic triblock copolymer with acid sensitivity and preparation method and application thereof |
| 02/06/2013 | CN102911348A Polyester/polyethyleneglycol block copolymer containing hydroxyl pendant group and application of polyester/polyethyleneglycol block copolymer |
| 02/06/2013 | CN102911326A Acid-sensitive degradable polymer vesicle and preparation and application thereof |
| 02/06/2013 | CN102911292A Preparation method of oxidized bagasse xylan |
| 02/06/2013 | CN102911071A Super-molecule complex containing amino acid and water-solubility pillar [5] arene and preparation method for complex |
| 02/06/2013 | CN102908961A Functional nanometer particle composite non-crosslinking microspheres and preparation method and application thereof |
| 02/06/2013 | CN102908629A Lipid-based drug of serum degradable carrier and application method of lipid-based drug |
| 02/06/2013 | CN102908628A Cellulose rhodophyta polysaccharide film coating premix and solution preparation method thereof |
| 02/06/2013 | CN102908627A pH-sensitive nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102908626A Method for preparing chitosan/ transparent acid derivative nanofiber composite film through freezing drying technology |
| 02/06/2013 | CN102908625A Chicken Newcastle disease and avian infectious bronchitis bivalent live vaccine heat-resistant protective agent and preparation process thereof |
| 02/06/2013 | CN102908611A Bioprotein dressing and bioprotein invisible film for preventing and controlling human papilloma virus infection |
| 02/06/2013 | CN102908609A Endoparasiticidal compositions |
| 02/06/2013 | CN102908550A Sugar-free vitamin C fructus forsythiae particles and preparation method thereof |
| 02/06/2013 | CN102908478A Moist and soft plaster for relieving muscles and strengthening bones |
| 02/06/2013 | CN102908441A Pain relieving micro-emulsion pharmaceutical composition gel ointment and preparation method thereof |
| 02/06/2013 | CN102908415A Preparation method of Bitongxiao cataplasm |
| 02/06/2013 | CN102908409A Production process of Chinese rhubarb fine powder granules |
| 02/06/2013 | CN102908377A Legalon dispersing tablet and preparation method thereof |
| 02/06/2013 | CN102908368A Preparation method of virus lyophilized preparation |
| 02/06/2013 | CN102908361A Compositions for treatment of mammalian diseases and methods of use |
| 02/06/2013 | CN102908359A Composite calcium carbonate/vitamin D3 granules for children and preparation method thereof |
| 02/06/2013 | CN102908354A Preparation method of butafosfan injection |
| 02/06/2013 | CN102908345A Drug composition suitable for transdermal drug delivery and containing granisetron as well as preparation and application of same |
| 02/06/2013 | CN102908344A Pharmaceutical composition comprising meropenem, and preparation method and application therof |
| 02/06/2013 | CN102908338A Preparation method of resveratrol microcapsule |
| 02/06/2013 | CN102908335A Rosuvastatain calcium composition and preparation method thereof |
| 02/06/2013 | CN102908332A Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102908330A Rubidate tablet and preparation method thereof |
| 02/06/2013 | CN102908327A Sustained release preparation for ivabradine or medicinal salt thereof |
| 02/06/2013 | CN102908326A Asparagine tablet and preparation method thereof |
| 02/06/2013 | CN102908325A Sevelamer carbonate medical tablet composition and preparation method thereof |
| 02/06/2013 | CN102908323A Moxifloxacin-containing pharmaceutical composition |
| 02/06/2013 | CN102908321A Albumin conjugated taxol nanoparticle freeze-dried preparation and preparation method thereof |
| 02/06/2013 | CN102908318A 10-hydroxycamptothecine nanometer microsphere and preparation method thereof |
| 02/06/2013 | CN102908317A Macrolide antibiotics enteric-coated pellets and coating solution thereof |
| 02/06/2013 | CN102908316A Ivermectin water-soluble solid dispersion and preparation method thereof |
| 02/06/2013 | CN102908315A Chitosan (CS) nanoparticle delivery system of small molecular interfering ribonucleic acid and preparation method thereof |
| 02/06/2013 | CN102908314A Silybin proliposomes preparation, and preparation method and application method thereof |
| 02/06/2013 | CN102908312A Liquid combination for resisting hepatitis B viruses |
| 02/06/2013 | CN102908311A Tolfenamic acid injection and preparation method and application thereof |
| 02/06/2013 | CN102908309A Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 02/06/2013 | CN102908307A Dronedarone hydrochloride pharmaceutical composition for injection and preparation method thereof |
| 02/06/2013 | CN102908305A Dronedarone hydrochloride-containing oral solid medicinal composition and preparation method thereof |
| 02/06/2013 | CN102408496B In-situ crosslinked alginate hydrogels and preparation method thereof |
| 02/06/2013 | CN102362856B Recombinant bovine basic fibroblast grow factor external solution |
| 02/06/2013 | CN102137659B Microparticles |
| 02/06/2013 | CN102133179B Stable cetirizine oral solution |
| 02/06/2013 | CN102058520B Cream for promoting tissue regeneration and restraining sores and preparation method thereof |
| 02/06/2013 | CN102037989B Aqueous compositions for disinfection and/or sterilization |
| 02/06/2013 | CN102014904B Liquid formulation for deferiprone with palatable taste |
| 02/06/2013 | CN101926786B Sustained release preparation for cantharidin and cantharidin extract |
| 02/06/2013 | CN101879427B Doxorubicin hydrochloride-carrying natural polymer-poly(3-benzene acid acrylamide) composite nanospheres, manufacturing method and application thereof |
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101583366B Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 02/06/2013 | CN101549146B Romurtide injection and preparation method thereof |
| 02/06/2013 | CN101262889B Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| 02/06/2013 | CN101227896B Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/05/2013 | US8367733 Composition for attenuation of pain or wound healing agents in dosage |
| 02/05/2013 | US8367631 Pharmaceutical composition which improves in vivo gene transfer |
| 02/05/2013 | US8367118 Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/05/2013 | US8367116 Buoyant polymer particles for delivery of therapeutic agents to the central nervous system |
| 02/05/2013 | US8367101 Comprising plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising solid matrix of polymer which contains drug, sub-units being connected together in assembled dosage form by a weld |
| 02/05/2013 | US8367082 Microgel and external compositions containing the same |
| 02/05/2013 | US8367078 Kinase inhibitor compounds |
| 02/05/2013 | US8367077 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 02/05/2013 | US8367070 Modified surface antigen |
| 02/05/2013 | US8367066 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 02/05/2013 | US8367065 Targeted polymeric prodrugs containing multifunctional linkers |
| 02/05/2013 | CA2723328C Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 02/05/2013 | CA2672551C Biodegradable block copolymeric compositions for drug delivery |
| 02/05/2013 | CA2572127C Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 02/05/2013 | CA2558738C Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 02/05/2013 | CA2526099C Freeze-dried fsh / lh formulations |
| 02/05/2013 | CA2523475C Pharmaceutical formulation comprising a water-insoluble active agent |
| 02/05/2013 | CA2521464C Irna conjugates |
| 02/05/2013 | CA2518903C Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 02/05/2013 | CA2512085C Protein complex, process for producing the same and use thereof |
| 02/05/2013 | CA2507762C Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 02/05/2013 | CA2472265C Immunogenic formulations of variable peptidic epitopes and process for preparation thereof |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 02/05/2013 | CA2410675C Medicament-loaded transdermal reservoir and method for its formation |
| 01/31/2013 | WO2013016697A2 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 01/31/2013 | WO2013016668A2 Methylphenidate-prodrugs, processes of making and using the same |
| 01/31/2013 | WO2013016544A2 Templated islet cells and small islet cell clusters for diabetes treatment |
| 01/31/2013 | WO2013016501A1 Formulations of thiophene compounds |
| 01/31/2013 | WO2013016494A1 Two part formulation system for ophthalmic delivery |
| 01/31/2013 | WO2013016125A1 Compositions and methods for the treatment of ocular surface allergies |
| 01/31/2013 | WO2013015821A1 Antibodies to the b12-transcobalamin receptor |
| 01/31/2013 | WO2013015704A1 System for delivering biologically active agents into an organism and method for producing said system |
| 01/31/2013 | WO2013015674A1 Collagen nanostructures |
| 01/31/2013 | WO2013015578A1 Sustained release tablet comprising pregabalin through two-phase release-controlling system |